Further investigations are needed to elucidate the functional role of FST in tumor biology and whether it presents a candidate target for small-molecule inhibition or is itself a molecule to enhance therapeutic response, ultimately improving health outcomes for cancer patients. The gene discussed is FST; the disease is neoplasm.